Dementia risk in AF comparable between DOACs, warfarin
Atrial fibrillation (AF) patients receiving warfarin do not appear to be at higher risk of dementia compared with their counterparts treated with direct oral anticoagulants (DOACs), with only edoxaban being associated with a lower risk, according to a study. Meanwhile, DOACs seem more beneficial among older patients with stroke history.